Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine - prolonged-release tablet - 50 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine - diazepines, oxazepines, thiazepines and oxepines - quentiax sr is indicated for:
treatment of schizophrenia
treatment of bipolar disorder: for the treatment of moderate to severe manic episodes in bipolar disorder for the treatment of major depressive episodes in bipolar disorder for the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment.
add-on treatment of major depressive episodes in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy (see section 5.1). prior to initiating treatment, clinicians should consider the safety profile of quentiax sr

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 150 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 200 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 300 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine hemifumarate - prolonged-release tablet - 400 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine